Open-Label Study of Levetiracetam in Body Dysmorphic Disorder.
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Levetiracetam (Primary)
- Indications Somatoform disorders
- Focus Therapeutic Use
- 09 Sep 2008 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
- 09 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Sep 2006 New trial record.